Kenvue /KVUE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Kenvue

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Ticker

KVUE

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Personal Care Products

Headquarters

Skillman, United States

Employees

22,000

Kenvue Metrics

BasicAdvanced
$35B
Market cap
23.28
P/E ratio
$0.78
EPS
-
Beta
$0.60
Dividend rate
3.29%
Dividend yield
$35B
$0.60
0.989
0.538
67.141
81.885
1,001.81%
6.52%
5.91%
9.65%
23.28
2.23
3.12
-4.55
16.58
3.29%
1.80%
-20.56%

What the Analysts think about Kenvue

Analyst Ratings

Majority rating from 16 analysts.
Hold

Kenvue Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.60% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.9B
6.22%
Net income
$296M
-9.48%
Profit margin
7.60%
-14.70%

Kenvue Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.63%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.32
$0.31
$0.31
$0.28
-
Expected
$0.30
$0.31
$0.28
$0.26
$0.28
Surprise
5.96%
-1.00%
10.66%
9.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kenvue stock?

Kenvue (KVUE) has a market cap of $35B as of July 03, 2024.

What is the P/E ratio for Kenvue stock?

The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 23.28 as of July 03, 2024.

Does Kenvue stock pay dividends?

Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $0.6 and the yield is 3.29%. Kenvue has a payout ratio of 1001.81% on a trailing twelve-month basis.

When is the next Kenvue dividend payment date?

The next Kenvue (KVUE) dividend payment date is unconfirmed.

What is the beta indicator for Kenvue ?

Kenvue (KVUE) does not currently have a Beta indicator.

Buy or sell Kenvue  stock

Buy or sell Kenvue stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing